Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Stem Cell Reports|November 15, 2024
Amendments to ASRM: Can we move away from a "Therapeutic Haven"?Tsunakuni Ikka, Taichi Hatta, Misao Fujita
Stem Cell Reports|April 22, 2022
Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in JapanTaichi Hatta, Kazuki Ide, Misao Fujita, et al.
Stem Cell Reports|October 25, 2024
The urgent need for clear and concise regulations on exosome-based interventionsMisao Fujita, Taichi Hatta, Tsunakuni Ikka, et al.
Stem Cell Reports|November 17, 2023
Does the Act on the Safety of Regenerative Medicine in Japan ensure "safety"?: Implications of low adverse event reportingTsunakuni Ikka, Taichi Hatta, Yoko Saito, et al.
Regenerative Therapy|October 2, 2018
Science communication in regenerative medicine: Implications for the role of academic society and science policyRyuma Shineha, Yusuke Inoue, Tsunakuni Ikka, et al.
International Journal of Clinical Oncology|October 10, 2025
Factors in oncologists' attitudes on do-not-attempt-resuscitation orders for patients with cancerMidori Kadowaki, Chikako Shimizu, Shimon Tashiro, et al.
Journal of Pain and Symptom Management|November 27, 2012
Oral nutrition or the ability to speak: the choice faced by a cancer survivorYutaka Hatano, Sawako Fujimoto, Tsunakuni Ikka, et al.
Therapeutic Innovation & Regulatory Science|October 10, 2019
Public Attitudes Toward the Secondary Uses of Patient Records for Pharmaceutical Companies' Activities in JapanHaruka Nakada, Yusuke Inoue, Keiichiro Yamamoto, et al.
Cancer Control : Journal of the Moffitt Cancer Center|October 25, 2025
Oncologists' Views and Communication Practices Regarding Unproven High-Cost Cancer Interventions in Private Medical Practice: A Questionnaire SurveyTsunakuni Ikka, Taichi Hatta, Noriyuki Katsumata, et al.
Pageof 2